|

Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia

RECRUITINGPhase 4Sponsored by Ain Shams University
Actively Recruiting
PhasePhase 4
SponsorAin Shams University
Started2023-11-17
Est. completion2025-05
Eligibility
Age2 Years – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06918054

Summary

This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.

Eligibility

Age: 2 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

Children and adolescents aged from 2 to 18 years newly diagnosed with acute lymphoblastic leukemia during induction phase of chemotherapy treated at Ain Shams

Exclusion Criteria:

Known chronic liver disease.

Conditions3

Acute Lymphoblastic LeukemiaCancerLeukaemia (Acute)

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.